EVI1 is critical for the pathogenesis of a subset of MLL-AF9-rearranged AMLs

被引:59
作者
Bindels, Eric M. J. [1 ]
Havermans, Marije [1 ]
Lugthart, Sanne [1 ]
Erpelinck, Claudia [1 ]
Wocjtowicz, Elizabeth [2 ]
Krivtsov, Andrei V. [3 ,4 ]
Rombouts, Elwin [1 ]
Armstrong, Scott A. [3 ,4 ]
Taskesen, Erdogan [1 ]
Haanstra, Jurgen R. [1 ]
Beverloo, H. Berna [5 ]
Doehner, Hartmut [6 ]
Hudson, Wendy A. [7 ]
Kersey, John H. [7 ]
Delwel, Ruud [1 ]
Kumar, Ashish R. [2 ,7 ]
机构
[1] Erasmus Univ, Med Ctr, Dept Hematol, NL-3015 GE Rotterdam, Netherlands
[2] Cincinnati Childrens Hosp, Med Ctr, Cincinnati, OH USA
[3] Childrens Hosp, Dana Farber Canc Inst, Div Hematol Oncol, Dept Pediat Oncol, Boston, MA 02115 USA
[4] Harvard Univ, Sch Med, Boston, MA USA
[5] Erasmus Univ, Med Ctr, Dept Clin Genet, Rotterdam, Netherlands
[6] Univ Ulm, Dept Internal Med 3, D-7900 Ulm, Germany
[7] Univ Minnesota, Masonic Canc Ctr, Minneapolis, MN USA
基金
美国国家卫生研究院;
关键词
ACUTE MYELOID-LEUKEMIA; HIGH BRE EXPRESSION; TRANSCRIPTIONAL ELONGATION; H3K79; METHYLATION; STEM-CELLS; MLL; GENE; BINDING; INTERACTS; CHROMATIN;
D O I
10.1182/blood-2011-11-393827
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The proto-oncogene EVI1 (ecotropic viral integration site-1), located on chromosome band 3q26, is aberrantly expressed in human acute myeloid leukemia (AML) with 3q26 rearrangements. In the current study, we showed, in a large AML cohort carrying 11q23 translocations, that similar to 43% of all mixed lineage leukemia (MLL)-rearranged leukemias are EVI1(pos). High EVI1 expression occurs in AMLs expressing the MLL-AF6, -AF9, -AF10, -ENL, or -ELL fusion genes. In addition, we present evidence that EVI1(pos) MLL-rearranged AMLs differ molecularly, morphologically, and immunophenotypically from EVI1(neg) MLL-rearranged leukemias. In mouse bone marrow cells transduced with MLL-AF9, we show that MLL-AF9 fusion protein maintains Evi1 expression on transformation of Evi1(pos) HSCs. MLL-AF9 does not activate Evi1 expression in MLL-AF9-transformed granulocyte macrophage progenitors (GMPs) that were initially Evi1(neg). Moreover, shRNA-mediated knockdown of Evi1 in an Evi1(pos) MLL-AF9 mouse model inhibits leukemia growth both in vitro and in vivo, suggesting that Evi1 provides a growth-promoting signal. Using the Evi1(pos) MLL-AF9 mouse leukemia model, we demonstrate increased sensitivity to chemotherapeutic agents on reduction of Evi1 expression. We conclude that EVI1 is a critical player in tumor growth in a subset of MLL-rearranged AMLs. (Blood. 2012; 119(24):5838-5849)
引用
收藏
页码:5838 / 5849
页数:12
相关论文
共 49 条
[31]   New insights to the MLL recombinome of acute leukemias [J].
Meyer, C. ;
Kowarz, E. ;
Hofmann, J. ;
Renneville, A. ;
Zuna, J. ;
Trka, J. ;
Ben Abdelali, R. ;
Macintyre, E. ;
De Braekeleer, E. ;
De Braekeleer, M. ;
Delabesse, E. ;
de Oliveira, M. P. ;
Cave, H. ;
Clappier, E. ;
van Dongen, J. J. M. ;
Balgobind, B. V. ;
van den Heuvel-Eibrink, M. M. ;
Beverloo, H. B. ;
Panzer-Gruemayer, R. ;
Teigler-Schlegel, A. ;
Harbott, J. ;
Kjeldsen, E. ;
Schnittger, S. ;
Koehl, U. ;
Gruhn, B. ;
Heidenreich, O. ;
Chan, L. C. ;
Yip, S. F. ;
Krzywinski, M. ;
Eckert, C. ;
Moericke, A. ;
Schrappe, M. ;
Alonso, C. N. ;
Schaefer, B. W. ;
Krauter, J. ;
Lee, D. A. ;
zur Stadt, U. ;
Kronnie, G. Te ;
Sutton, R. ;
Izraeli, S. ;
Trakhtenbrot, L. ;
Lo Nigro, L. ;
Tsaur, G. ;
Fechina, L. ;
Szczepanski, T. ;
Strehl, S. ;
Ilencikova, D. ;
Molkentin, M. ;
Burmeister, T. ;
Dingermann, T. .
LEUKEMIA, 2009, 23 (08) :1490-1499
[32]   Multiple Interactions Recruit MLL1 and MLL1 Fusion Proteins to the HOXA9 Locus in Leukemogenesis [J].
Milne, Thomas A. ;
Kim, Jaehoon ;
Wang, Gang G. ;
Stadler, Sonja C. ;
Basrur, Venkatesha ;
Whitcomb, Sarah J. ;
Wang, Zhanxin ;
Ruthenburg, Alexander J. ;
Elenitoba-Johnson, Kojo S. J. ;
Roeder, Robert G. ;
Allis, C. David .
MOLECULAR CELL, 2010, 38 (06) :853-863
[33]   RETROVIRAL ACTIVATION OF A NOVEL GENE ENCODING A ZINC FINGER PROTEIN IN IL-3-DEPENDENT MYELOID-LEUKEMIA CELL-LINES [J].
MORISHITA, K ;
PARKER, DS ;
MUCENSKI, ML ;
JENKINS, NA ;
COPELAND, NG ;
IHLE, JN .
CELL, 1988, 54 (06) :831-840
[34]   A role for the MLL fusion partner ENL in transcriptional elongation and chromatin modification [J].
Mueller, Dorothee ;
Bach, Christian ;
Zeisig, Deniz ;
Garcia-Cuellar, Maria-Paz ;
Monroe, Sara ;
Sreekumar, Arun ;
Zhou, Rong ;
Nesvizhskii, Alexey ;
Chinnaiyan, Arul ;
Hess, Jay L. ;
Slany, Robert K. .
BLOOD, 2007, 110 (13) :4445-4454
[35]   The PAF Complex Synergizes with MLL Fusion Proteins at HOX Loci to Promote Leukemogenesis [J].
Muntean, Andrew G. ;
Tan, Jiaying ;
Sitwala, Kajal ;
Huang, Yongsheng ;
Bronstein, Joel ;
Connelly, James A. ;
Basrur, Venkatesha ;
Elenitoba-Johnson, Kojo S. J. ;
Hess, Jay L. .
CANCER CELL, 2010, 17 (06) :609-621
[36]   High BRE expression predicts favorable outcome in adult acute myeloid leukemia, in particular among MLL-AF9-positive patients [J].
Noordermeer, Sylvie M. ;
Sanders, Mathijs A. ;
Gilissen, Christian ;
Tonnissen, Evelyn ;
van der Heijden, Adrian ;
Doehner, Konstanze ;
Bullinger, Lars ;
Jansen, Joop H. ;
Valk, Peter J. M. ;
van der Reijden, Bert A. .
BLOOD, 2011, 118 (20) :5613-5621
[37]   EVI-1, A MURINE ZINC FINGER PROTOONCOGENE, ENCODES A SEQUENCE-SPECIFIC DNA-BINDING PROTEIN [J].
PERKINS, AS ;
FISHEL, R ;
JENKINS, NA ;
COPELAND, NG .
MOLECULAR AND CELLULAR BIOLOGY, 1991, 11 (05) :2665-2674
[38]   Relation between age, immunophenotype and in vitro drug resistance in 395 children with acute lymphoblastic leukemia -: implications for treatment of infants [J].
Pieters, R ;
den Boer, ML ;
Durian, M ;
Janka, G ;
Schmiegelow, K ;
Kaspers, GJL ;
van Wering, ER ;
Veerman, AJP .
LEUKEMIA, 1998, 12 (09) :1344-1348
[39]   EXPRESSION OF EVI1 IN MYELODYSPLASTIC SYNDROMES AND OTHER HEMATOLOGIC MALIGNANCIES WITHOUT 3Q26 TRANSLOCATIONS [J].
RUSSELL, M ;
LIST, A ;
GREENBERG, P ;
WOODWARD, S ;
GLINSMANN, B ;
PARGANAS, E ;
IHLE, J ;
TAETLE, R .
BLOOD, 1994, 84 (04) :1243-1248
[40]   The Oncoprotein EVI1 and the DNA Methyltransferase Dnmt3 Co-Operate in Binding and De Novo Methylation of Target DNA [J].
Senyuk, Vitalyi ;
Premanand, Kavitha ;
Xu, Peng ;
Qian, Zhijian ;
Nucifora, Giuseppina .
PLOS ONE, 2011, 6 (06)